Avoro Capital Advisors LLC Veracyte, Inc. Transaction History

Avoro Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$5.39 - $9.66 $645,075 - $1.16 Million	-119,680 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$5.44 - $6.97 $3.44 Million - $4.41 Million	-632,775 Reduced 84.09%	119,680 $665,000
Q4 2017 Feb 14, 2018	SELL	$6.05 - $9.37 $1.12 Million - $1.73 Million	-184,454 Reduced 19.69%	752,455 $4.91 Million
Q3 2017 Nov 14, 2017	BUY	$7.81 - $8.77 $7.32 Million - $8.22 Million	936,909	936,909 $8.22 Million

311

82M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.14B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.